[HTML][HTML] Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy
S Prasad, E Kalafat, H Blakeway, R Townsend… - Nature …, 2022 - nature.com
Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …
mRNA vaccines in the COVID-19 pandemic and beyond
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around …
disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around …
[HTML][HTML] SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
SJ Stock, J Carruthers, C Calvert, C Denny… - Nature medicine, 2022 - nature.com
Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …
[HTML][HTML] Maternal vaccination and risk of hospitalization for Covid-19 among infants
Background Infants younger than 6 months of age are at high risk for complications of
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …
COVID-19 vaccination during pregnancy: coverage and safety
Background Concerns have been raised regarding a potential surge of COVID-19 in
pregnancy, secondary to the rising numbers of COVID-19 in the community, easing of …
pregnancy, secondary to the rising numbers of COVID-19 in the community, easing of …
[HTML][HTML] Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
Pregnant patients with COVID-19 are more likely to require intensive care and die compared
with noninfected pregnant women. While the consequences of COVID-19 disease in …
with noninfected pregnant women. While the consequences of COVID-19 disease in …
[PDF][PDF] Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
K Bok, S Sitar, BS Graham, JR Mascola - Immunity, 2021 - cell.com
The development of effective vaccines to combat infectious diseases is a complex multi-year
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study
Background Some studies have suggested that women with SARS-CoV-2 infection during
pregnancy are at increased risk of adverse pregnancy and neonatal outcomes, but these …
pregnancy are at increased risk of adverse pregnancy and neonatal outcomes, but these …
[HTML][HTML] COVID-19 mRNA vaccines: Platforms and current developments
GT Szabó, AJ Mahiny, I Vlatkovic - Molecular Therapy, 2022 - cell.com
Since the first successful application of messenger ribonucleic acid (mRNA) as a vaccine
agent in a preclinical study nearly 30 years ago, numerous advances have been made in …
agent in a preclinical study nearly 30 years ago, numerous advances have been made in …
[HTML][HTML] Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons
TT Shimabukuro, SY Kim, TR Myers… - … England Journal of …, 2021 - Mass Medical Soc
Background Many pregnant persons in the United States are receiving messenger RNA
(mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety …
(mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety …